Eileen Pruette is EVP & General Counsel at VALEANT PHARMACEUTICALS INTERNATIONAL (VRX). They have made 1 open-market trade across 1 company since 2006, most recently 2007-10-30.
CIK 0001232213
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $25K since 2006, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VRX | 26,446 | $619K |
Shares reported on the most recent Form 4, priced at the 2007-11-01 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VRX | BUY | 2006-05-25 | 2006-05-26 | $16.56 | $25K | -12.8% | +0.4% | +0.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.